CytoSorbents Reports Fourth Quarter and Full Year 2022 Results

March 9, 2023

https://www.globenewswire.com/news-release/2023/03/09/2624614/25359/en/CytoSorbents-Reports-Fourth-Quarter-and-Full-Year-2022-Results.html

Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2022 continues in Q1 2023 to date, with expectation of sales growth in 2023

Read more at globenewswire.com

Related news for (CTSO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.